AcuFocus received FDA approval for its IC-8 Apthera small-aperture IOL for cataract surgery, according to a press release.
The extended depth of focus lens will be launched with a limited commercial release in the fall.
The IOL has small-aperture technology that filters out peripheral defocused light, which allows only focused light to reach the retina, the release said. In the U.S. investigational device exemption study, which included 453 participants and evaluated the effectiveness and safety of the lens, the Apthera IOL implanted in one eye and a monofocal or monofocal toric IOL in the